Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.5K
Clinical Trials01:16

Clinical Trials

9.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.4K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.0K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

815
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
815
Drug Discovery: Overview01:26

Drug Discovery: Overview

9.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.1K
Blinding01:11

Blinding

3.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Implementation of a Machine Learning Model for Prediction of Surgical Case Duration.

Joint Commission journal on quality and patient safety·2026
Same author

Strategic governance of integrated nuclear medicine, diagnostic radiology, and radiation therapy in comprehensive cancer centres: A balanced scorecard framework.

Journal of cancer policy·2026
Same author

Technical Considerations on Proton Therapy in NRG's Multi-Institutional Clinical Trials.

International journal of radiation oncology, biology, physics·2026
Same author

A strategy of CT exam protocol to standardize groups of scanners using automated noise assessment and noise prediction for CT radiotherapy simulation.

Biomedical physics & engineering express·2026
Same author

Sensitivity and concordance study of an open source EPID-based linear accelerator test suite.

Journal of applied clinical medical physics·2026
Same author

C. Norman Coleman's Legacy in Radiation Research and Global Health: A Cancer Research and Care Perspective.

Disaster medicine and public health preparedness·2026
Same journal

A computer-aided diagnosis tool in prostate cancer patients with biochemical recurrence using 18F-PSMA PET/CT imaging.

Medical physics·2026
Same journal

Investigating the uncertainty of cellular microenvironment parameter estimations via diffusion MRI cytometry.

Medical physics·2026
Same journal

Correction to "On the shape of the radiation survival curve in tumor spheroids: The role of oxygen heterogeneity".

Medical physics·2026
Same journal

Multi-view constrained semi-supervised vertebra detection for 3D ultrasound spine volume.

Medical physics·2026
Same journal

Accuracy of quantitative <sup>177</sup>Lu SPECT/CT imaging: A systematic review.

Medical physics·2026
Same journal

Physics-constrained dual-domain network for CBCT reconstruction from orthogonal X-rays in gynecologic radiotherapy.

Medical physics·2026
See all related articles

Related Experiment Video

Updated: Sep 28, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K

A roadmap to clinical trials for FLASH.

Paige A Taylor1, Jean M Moran2, David A Jaffray1

  • 1The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Medical Physics
|April 2, 2022
PubMed
Summary
This summary is machine-generated.

FLASH radiation therapy shows promise but requires further research into its radiobiological mechanisms and safety. Careful implementation and quality assurance are crucial for successful clinical trials and patient outcomes.

Keywords:
FLASHadvanced technologyclinical trialsquality assuranceradiation therapyultra-high dose rate

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.3K

Related Experiment Videos

Last Updated: Sep 28, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.3K

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Radiobiology

Background:

  • FLASH radiation therapy (FLASH-RT) is a novel approach generating significant interest.
  • Its radiobiological mechanisms and clinical implementation complexities are not yet fully understood.

Purpose of the Study:

  • To review current quality assurance and safety systems for FLASH-RT.
  • To identify critical pre-clinical data needed for its advancement.
  • To propose a path for evidence-driven clinical implementation.

Main Methods:

  • Review of existing literature on FLASH-RT quality assurance and safety.
  • Analysis of challenges in clinical translation, drawing parallels with other advanced radiotherapy techniques.
  • Identification of key pre-clinical research areas.

Main Results:

  • FLASH-RT requires rigorous dosimetry, advanced planning, and image guidance, similar to conventional radiotherapy.
  • Standardized credentialing is necessary for multi-institutional clinical trials.
  • A cautious, evidence-based approach is recommended for clinical progression.

Conclusions:

  • FLASH-RT holds promise but necessitates deliberate and cautious advancement towards clinical trials.
  • Lessons from previous technological implementations in radiation oncology are vital for successful FLASH-RT integration.
  • Addressing safety, consistency, and radiobiological understanding is paramount.